Skip to main content
Top
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Research article

International external quality control assessment for the serological diagnosis of dengue infections

Authors: Cristina Domingo, María Joao Alves, Fernando de Ory, Anette Teichmann, Herbert Schmitz, Rolf Müller, Matthias Niedrig

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Abstract

Background

Dengue is endemic to the tropics and subtropics, and the most frequent of arthropod-borne viral diseases. Reliable diagnosis of dengue infection is important not only in clinical care but also in disease surveillance, the control of outbreaks, and the development of new vaccines. The diagnosis of dengue infection is usually established by a variety of commercial or in-house serological protocols. The European Network for the Diagnostics of Imported Viral Diseases (ENIVD) recognized the need to survey the accuracy of dengue serological diagnostics in current use, and organized an external quality assurance (EQA) study of dengue serological practice in diagnostic laboratories.

Methods

A 15-sample panel, consisting of sera reactive against dengue plus specificity and negative controls, was sent to 48 laboratories for serological testing. The results returned by the participating laboratories were anonymized, scored, and subjected to comparison and statistical analysis.

Results

Ten laboratories rated all samples correctly with regard to IgM, and only three achieved the full score for IgG detection. The main handicaps in assay performance were suboptimal sensitivity of in-house IgM detection protocols by comparison with better-performing commercial ELISA tests, and the presence of IgG cross-reactivity with heterologous flaviviruses. Differences of detail in the methodology of dengue IgG antibody detection appear to underlie the disparities in accuracy observed between laboratories.

Conclusion

This EQA study demonstrates that there is room for many laboratories to improve sensitivity in the detection of anti-dengue virus IgM antibodies, against the benchmark set by commercial antibody capture ELISA tests. The EQA shows also that cross-reactivity is a continuing issue, and IgG detection protocols must be optimized to increase their specificity.
Appendix
Available only for authorised users
Literature
1.
3.
go back to reference WHO/TDR. 2009. Dengue: guidelines for diagnosis, treatment, prevention and control. New Edition 2009 WHO/TDR. 2009. Dengue: guidelines for diagnosis, treatment, prevention and control. New Edition 2009
4.
go back to reference Chen LH, Wilson ME. Dengue and chikungunya in travelers: recent updates. Curr Opin Infect Dis. 2012;25:523–9.CrossRefPubMed Chen LH, Wilson ME. Dengue and chikungunya in travelers: recent updates. Curr Opin Infect Dis. 2012;25:523–9.CrossRefPubMed
5.
go back to reference European Centre for Disease Control and Prevention. 2013. Dengue outbreak in Madeira, Portugal, October–November 2012. ECDC. European Centre for Disease Control and Prevention. 2013. Dengue outbreak in Madeira, Portugal, October–November 2012. ECDC.
6.
go back to reference Vega-Rua A, Zouache K, Caro V, Diancourt L, Delaunay P, Grandadam M, et al. High efficiency of temperate Aedes albopictus to transmit chikungunya and dengue viruses in the Southeast of France. PLoS One. 2013;8:e59716.CrossRefPubMedPubMedCentral Vega-Rua A, Zouache K, Caro V, Diancourt L, Delaunay P, Grandadam M, et al. High efficiency of temperate Aedes albopictus to transmit chikungunya and dengue viruses in the Southeast of France. PLoS One. 2013;8:e59716.CrossRefPubMedPubMedCentral
7.
go back to reference Talbalaghi A, Moutailler S, Vazeille M, Failloux AB. Are Aedes albopictus or other mosquito species from northern Italy competent to sustain new arboviral outbreaks? Med Vet Entomol. 2010;24:83–7.CrossRefPubMed Talbalaghi A, Moutailler S, Vazeille M, Failloux AB. Are Aedes albopictus or other mosquito species from northern Italy competent to sustain new arboviral outbreaks? Med Vet Entomol. 2010;24:83–7.CrossRefPubMed
12.
go back to reference European Centre for Disease Control and Prevention. 2013. Communicable disease threats report-week 1. European Centre for Disease Control and Prevention. 2013. Communicable disease threats report-week 1.
13.
go back to reference Peeling RW, Artsob H, Pelegrino JL, Buchy P, Cardosa MJ, Devi S, et al. Evaluation of diagnostic tests: dengue. Nat Rev Microbiol. 2010;8:S30–8.CrossRefPubMed Peeling RW, Artsob H, Pelegrino JL, Buchy P, Cardosa MJ, Devi S, et al. Evaluation of diagnostic tests: dengue. Nat Rev Microbiol. 2010;8:S30–8.CrossRefPubMed
14.
go back to reference Domingo C, de Ory F, Sanz JC, Reyes N, Gascon J, Wichmann O, et al. Molecular and serologic markers of acute dengue infection in naive and flavivirus-vaccinated travelers. Diagn Microbiol Infect Dis. 2009;65:42–8.CrossRefPubMed Domingo C, de Ory F, Sanz JC, Reyes N, Gascon J, Wichmann O, et al. Molecular and serologic markers of acute dengue infection in naive and flavivirus-vaccinated travelers. Diagn Microbiol Infect Dis. 2009;65:42–8.CrossRefPubMed
15.
go back to reference Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, Enria DA, et al. Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Emerg Infect Dis. 2009;15:436–40.CrossRefPubMedPubMedCentral Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, Enria DA, et al. Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Emerg Infect Dis. 2009;15:436–40.CrossRefPubMedPubMedCentral
16.
go back to reference Niedrig M, Donoso-Mantke O, Schadler R, members E. The European Network for Diagnostics of Imported Viral Diseases (ENIVD)–12 years of strengthening the laboratory diagnostic capacity in Europe. Euro Surveillance. 2007;12(E070419):070415. Niedrig M, Donoso-Mantke O, Schadler R, members E. The European Network for Diagnostics of Imported Viral Diseases (ENIVD)–12 years of strengthening the laboratory diagnostic capacity in Europe. Euro Surveillance. 2007;12(E070419):070415.
17.
go back to reference Donoso Mantke O, Lemmer K, Biel SS, Groen J, Schmitz H, Durand JP, et al. Quality control assessment for the serological diagnosis of dengue virus infections. J Clin Virol. 2004;29:105–12.CrossRefPubMed Donoso Mantke O, Lemmer K, Biel SS, Groen J, Schmitz H, Durand JP, et al. Quality control assessment for the serological diagnosis of dengue virus infections. J Clin Virol. 2004;29:105–12.CrossRefPubMed
Metadata
Title
International external quality control assessment for the serological diagnosis of dengue infections
Authors
Cristina Domingo
María Joao Alves
Fernando de Ory
Anette Teichmann
Herbert Schmitz
Rolf Müller
Matthias Niedrig
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-0877-0

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue